½ÃÀ庸°í¼
»óÇ°ÄÚµå
1498663
¼¼°èÀÇ Ç³¼±ÆǸ·¼ºÇü¼ú µð¹ÙÀ̽º ½ÃÀå Á¶»ç º¸°í¼ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)Global Balloon Valvuloplasty Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
dz¼±ÆǸ·¼ºÇü¼ú µð¹ÙÀ̽º ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 29¾ï 7,000¸¸ ´Þ·¯¿¡¼ 2032³â¿¡´Â ¾à 47¾ï 5,000¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2024-2032³â CAGRÀº 5.36%ÀÔ´Ï´Ù.
dz¼±ÆǸ·¼ºÇü¼ú µð¹ÙÀ̽º´Â ÇùÂøµÈ ½ÉÀå ÆǸ·À» Ä¡·áÇϱâ À§ÇÑ ÀÇ·á±â±â·Î, ÀϹÝÀûÀ¸·Î ´ëµ¿¸Æ ÆǸ·À̳ª ½Â¸ðÆǸ· µî ÇùÂøµÈ ½ÉÀå ÆǸ·À» ³ÐÇôÁÖ´Â ½Ã¼ú¿¡ »ç¿ëµË´Ï´Ù. ÀÌ °úÁ¤¿¡¼ dz¼±ÀÌ ºÎÂøµÈ Ä«Å×Å͸¦ Ç÷°üÀ» ÅëÇØ ÇØ´ç ºÎÀ§ÀÇ ÆǸ·¿¡ »ðÀÔÇÕ´Ï´Ù. dz¼±À» Á¦ÀÚ¸®¿¡ ¼³Ä¡ÇÑ ÈÄ Ç³¼±À» ºÎÇ®·Á ÆǸ· ÀÔ±¸¸¦ ³ÐÇô Ç÷·ù¸¦ °³¼±ÇÏ°í Áõ»óÀ» ¿ÏÈÇÕ´Ï´Ù. dz¼±ÆǸ·¼ºÇü¼úÀº ÆǸ· ġȯ¼úÀ» ´ëüÇÒ ¼ö ÀÖ´Â ÃÖ¼Ò Ä§½ÀÀû ¼ö¼ú·Î, ƯÁ¤ ȯÀÚÀÇ °æ¿ì ȸº¹ ½Ã°£À» ´ÜÃàÇÏ°í À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. dz¼±ÆǸ·¼ºÇü¼úÀº ÀϹÝÀûÀ¸·Î ¼Ò¾Æ ¼øȯ±â³»°ú ¹× °³½É¼úÀÌ ÀûÇÕÇÏÁö ¾ÊÀº ȯÀÚ¿¡°Ô »ç¿ëµË´Ï´Ù.
dz¼±ÆǸ·¼ºÇü¼ú µð¹ÙÀ̽º ½ÃÀåÀº °í·ÉÈ¿Í ½ÉÇ÷°ü À§Çè ¿ä¼Ò Áõ°¡·Î ÀÎÇØ ´ëµ¿¸ÆÆǸ· ÇùÂøÁõ ¹× ½Â¸ðÆǸ· Æó¼âºÎÀüÁõ°ú °°Àº ½ÉÀå ÆǸ· ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó dz¼±ÆǸ·¼ºÇü¼ú°ú °°Àº Àúħ½ÀÀû Ä¡·á¹ý¿¡ ´ëÇÑ ½ÃÀå ¼ö¿ä¸¦ ÁÖµµÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ ºÎ´ã Áõ°¡´Â ¿Ü°úÀû °³ÀÔÀ» ´ëüÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÌ°í ´ú ħ½ÀÀûÀÎ Ä¡·á¹ýÀÇ Çʿ伺À» °Á¶ÇÏ¸ç ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. Â÷¼¼´ë Ä«Å×ÅÍ ¹× Àü´Þ ½Ã½ºÅÛ °³¹ß µî dz¼±ÆǸ·¼ºÇü¼ú ±â±âÀÇ ±â¼ú ¹ßÀüÀº ½Ã¼ú ¼º°ø·ü°ú ȯÀÚ ¿¹Èĸ¦ Çâ»ó½ÃÄÑ ´Ù¾çÇÑ ÀÓ»ó ÇöÀå¿¡¼ÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. dz¼±ÆǸ·¼ºÇü¼úÀÇ ÀûÀÀÁõÀÌ ±âÁ¸ °íÀ§Çè ¼ö¼ú ȯÀÚ»Ó¸¸ ¾Æ´Ï¶ó ÀúÀ§Çè ȯÀÚ ¹× °í·ÉÀÚ±îÁö È®´ëµÇ¸é¼ ½ÃÀåÀÇ ¹üÀ§¿Í °¡´É¼ºÀº ´õ¿í È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Æ¯È÷ ½ÅÈï ±¹°¡ÀÇ ÀÇ·áºñ Áõ°¡¿Í ½ÉÇ÷°ü Ä¡·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀڴ dz¼±ÆǸ·¼ºÇü¼ú°ú °°Àº ÷´Ü Ä¡·á¹ý¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇÏ¸ç ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÃÀå Á¢±ÙÀ» ÃËÁøÇÏ°í ȯÀÚÀÇ ¾ÈÀü°ú ÀÇ·áÀÇ ÁúÀ» º¸ÀåÇϱâ À§ÇÑ Áö¿øÀûÀÎ »óȯ Á¤Ã¥ ¹× ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ dz¼±ÆǸ·¼ºÇü¼ú ±â±â¿¡ ´ëÇÑ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÀáÀçÀûÀÎ ÇÕº´Áõ°ú ³ôÀº ½Ã¼ú ºñ¿ëÀº ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
ÀÌ Á¶»ç ¸®Æ÷Æ®¿¡¼´Â Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆľÇÇÏ°í, ¼¼°è ·¹º§¿¡¼ÀÇ °æÀï ¸Å·ÂÀ» Æò°¡Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ ÅøÀº dz¼± º¯Çü¼º Àåºñ ¼¼°è ½ÃÀå¿¡¼ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. dz¼±ÆǸ·¼ºÇü¼ú µð¹ÙÀ̽º »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»çÀÇ ÀüüÀûÀÎ ¾îÇÁ·ÎÄ¡¸¦ Á¦°øÇÕ´Ï´Ù.
dz¼±ÆǸ·¼ºÇü¼ú µð¹ÙÀ̽º ½ÃÀå º¸°í¼ÀÇ ÀÌ ¼½¼Ç¿¡¼´Â ±¹°¡º° ¹× Áö¿ªº° ºÎ¹®¿¡ °üÇÑ »ó¼¼ µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â °ÍÀ¸·Î, Àü·« ´ã´çÀÚ°¡ ÇâÈÄ ±âȸ¿Í ÇÔ²² °¢°¢ÀÇ Á¦Ç° ¹× ¼ºñ½ºÀÇ ´ë»óÃþÀ» ½Äº°Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù.
º» ¼½¼Ç¿¡¼´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¾ÆÇÁ¸®Ä«¿¡¼ dz¼±ÆǸ·¼ºÇü¼ú µð¹ÙÀ̽º ½ÃÀåÀÇ ÇöÀç ¹× ÇâÈÄ ¼ö¿ä¸¦ ºÐ¸íÈ÷ ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼ °³º° ¿ëµµ ºÎ¹®ÀÇ ¼ö¿ä, ÃßÁ¤¡¤¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
Ä¿½ºÅÒ ¿ä°ÇÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. Value Market ResearchÀÇ Á¶»çÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü ¸®Æ÷Æ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
The global demand for Balloon Valvuloplasty Devices Market is presumed to reach the market size of nearly USD 4.75 Billion by 2032 from USD 2.97 Billion in 2023 with a CAGR of 5.36% under the study period 2024-2032.
Balloon valvuloplasty devices are medical tools used to treat stenotic heart valves, typically in procedures to widen narrowed heart valves, such as the aortic or mitral valves. The process entails threading a catheter with an attached balloon through the blood vessels to the affected valve. Once in place, the balloon is inflated to enlarge the valve opening, improving blood flow and reducing symptoms. Balloon valvuloplasty is a minimally invasive alternative to valve replacement surgery, offering shorter recovery times and reduced risks for certain patients. It is commonly used in pediatric cardiology and for patients not candidates for open-heart surgery.
The balloon valvuloplasty devices market is driven by the increasing prevalence of valvular heart diseases, such as aortic stenosis and mitral regurgitation, due to aging populations and the escalating incidence of cardiovascular risk factors, drives market demand for minimally invasive treatment options like balloon valvuloplasty. This growing disease burden underscores the need for effective & less invasive alternatives to surgical interventions, fuelling market growth. Technological advancements in balloon valvuloplasty devices, including the development of next-generation catheters and delivery systems, enhance procedural success rates and patient outcomes, driving adoption across a wider range of clinical settings. Expanding indications for balloon valvuloplasty beyond traditional high-risk surgical patients to include lower-risk and elderly populations further broadens the market's scope and potential. Moreover, increasing healthcare expenditure and investments in cardiovascular care infrastructure, particularly in emerging economies, contribute to market growth by expanding access to advanced treatment modalities like balloon valvuloplasty. Furthermore, supportive reimbursement policies and regulatory frameworks aimed at facilitating market access and ensuring patient safety and quality of care stimulate market demand for balloon valvuloplasty devices. However, potential complications and the high cost of the procedure may challenge the market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Balloon Valvuloplasty Devices. The growth and trends of Balloon Valvuloplasty Devices industry provide a holistic approach to this study.
This section of the Balloon Valvuloplasty Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Balloon Valvuloplasty Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Balloon Valvuloplasty Devices market include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, Company, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Innomed Medical Development Ltd., Jotech GmbH, Medtronic Plc, Microport Scientific Corporation, Numed Canada Inc., NuMED Inc., Osypka Medical GmbH, Teleflex Incorporated. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.